PUBLICATIONS
If you would like a .pdf not available via the links below, please e-mail to LoisLampson@hotmail.com
Brain tumor models to predict clinical outcome: Like the phoenix?
Lampson LA. In Animal Models of Brain Tumors (Murillo, RM, Martinez, R, Eds.), Humana, 2013. Publisher
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.
Lampson LA. MAbs 3, 153-160, 2011. PDF
Targeted therapy for neuro-oncology: reviewing the menu.
Lampson LA. Drug Discov. Today 14, 185-191, 2009. PubMed
Immune regulation in the brain: lessons from autoimmunity, implications for brain tumor therapy.
Lampson, LA. In Brain Tumors (Ali-Osman, F, Ed.), Humana, 2005. Publisher
Basic principles of CNS immunology.
Lampson LA. In Youmans Neurological Surgery (Winn, HR, Ed.) 5th ed., Saunders, 2003. Publisher
Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.
Dutta T, Spence A, Lampson LA. Journal of Neuro-oncology 64, 31-44, 2003. PubMed
Brain tumor immunotherapy: an immunologist's perspective.
Lampson LA. Journal of Neuro-oncology 64, 3-11, 2003. PubMed
Local immune regulation in the central nervous system by substance P vs. glutamate.
McCluskey LP, Lampson LA. J. Neuroimmunol. 116, 136-146, 2001. PubMed
New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns.
Lampson LA. Journal of Neuro-oncology 53, 275-287, 2001. PubMed
Local neurochemicals and site-specific immune regulation in the CNS.
McCluskey LP, Lampson LA. J. Neuropathol. Exp. Neurol. 59, 177-187, 2000. PubMed
Site-specific immune regulation in the brain: differential modulation of major histocompatibility complex (MHC) proteins in brainstem vs. hippocampus. Phillips LM, Simon PJ, Lampson LA. J. Comp. Neurol. 405, 322-333, 1999. PubMed
Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma.
Phillips LM, Lampson LA. J. Neuroimmunol. 96, 218-227, 1999. PubMed
Beyond inflammation: site-directed immunotherapy.
Lampson LA. Immunol. Today 19, 17-22, 1998. PubMed
MHC expression in nonlymphoid tissues of the developing embryo: strongest class I or class II expression in separate populations of potential antigen-presenting cells in the skin, lung, gut, and inter-organ connective tissue.
Grabowska A, Lampson LA. Dev. Comp. Immunol. 19, 425-450, 1995. PubMed
Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings.
Lampson LA. Microsc. Res. Tech. 32, 267-285, 1995. PubMed
Class I and II MHC expression and its implications for regeneration in the nervous system.
Lampson LA, Grabowska A, Whelan JP. Prog. Brain Res. 103, 307-317, 1994. PubMed
Enhanced T cell migration to sites of microscopic CNS disease: complementary treatments evaluated by 2- and 3-D image analysis.
Lampson LA, Chen A, Vortmeyer AO, Sloan AE, Ghogawala Z, Kim L. Brain Pathol 4, 125-134, 1994. PubMed
Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.
Lehky TJ, Cowan EP, Lampson LA, Jacobson S. J. Virol. 68, 1854-1863, 1994. PDF
Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. Drew PD, Lonergan M, Goldstein ME, Lampson LA, Ozato K, McFarlin DE. J. Immunol. 150, 3300-3310, 1993. PDF
Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumor growth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ.
Lampson LA, Lampson MA, Dunne AD. Cancer Res. 53, 176-182, 1993. PDF
Disseminating tumor cells and their interactions with leukocytes visualized in the brain.
Lampson LA, Wen P, Roman VA, Morris JH, Sarid JA. Cancer Res. 52, 1018-1025, 1992. PDF
Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy. Wen PY, Lampson MA, Lampson LA. J. Neuroimmunol. 36, 57-68, 1992. PubMed
Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. Sethna MP, Lampson LA. J. Neuroimmunol. 34, 121-132, 1991. PubMed
Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Kassis AI, Van den Abbeele AD, Wen PY, Baranowska-Kortylewicz J, Aaronson RA, DeSisto WC, Lampson LA, Black PM, Adelstein SJ. Cancer Res. 50, 5199-5203, 1990. PDF
The effects of irradiation on major histocompatibility complex expression and lymphocytic infiltration in the normal rat brain and the 9L gliosarcoma brain tumor model. Wen P, Loeffler JS, Morris JH, Lampson LA. J. Neuroimmunol. 27, 239-244, 1990. PubMed
Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis.
Lampson LA, Kushner PD, Sobel RA. Ann. Neurol. 28, 365-372, 1990. PubMed
MHC regulation in neural cells. Distribution of peripheral and internal beta 2-microglobulin and class I molecules in human neuroblastoma cell lines.
Lampson LA. J. Immunol. 144, 512-520, 1990. PDF
Human neuroblastoma cell growth in xenogeneic hosts: comparison of T cell-deficient and NK-deficient hosts, and subcutaneous or intravenous injection routes. Turner WJ, Chatten J, Lampson LA. Journal of Neuro-oncology 8, 121-132, 1990. PubMed
Biological significance of HLA-A,B,C expression in neuroblastoma and related cell lines.
Lampson LA. Prog Clin Biol Res 271, 409-420, 1988. PubMed
IFN-treated neuroblastoma cell lines remain resistant to T cell-mediated allo-killing, and susceptible to non-MHC-restricted cytotoxicity.
Main EK, Monos DS, Lampson LA. J. Immunol. 141, 2943-2950, 1988. PDF
Defining the mechanisms that govern immune acceptance or rejection of neural tissue.
Lampson LA, Siegel G. Prog. Brain Res. 78, 243-247, 1988. PubMed
Functional implications of class I MHC modulation in neural tissue.
Lampson LA, Whelan JP, Siegel G. Ann. N. Y. Acad. Sci. 540, 479-482, 1988. PubMed
Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis.
Lavi E, Suzumura A, Lampson LA, Siegel RM, Murasko DM, Silberberg DH, Weiss SR. Adv. Exp. Med. Biol. 218, 219-222, 1987. PubMed
Interferon-mediated induction of class I MHC products in human neuronal cell lines: analysis of HLA and beta 2-m RNA, and HLA-A and HLA-B proteins and polymorphic specificities. Lampson LA, George DL. J Interferon Res 6, 257-265, 1986. PubMed
Molecular specificity of defined types of amacrine synapse in cat retina.
Sterling P, Lampson LA. J. Neurosci. 6, 1314-1324, 1986. PDF
Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. Lampson LA, Hickey WF. J. Immunol. 136, 4054-4062, 1986. PDF
Expression of mouse beta 2-microglobulin in frozen and formaldehyde-fixed central nervous tissues: comparison of tissue behind the blood-brain barrier and tissue in a barrier-free region. Whelan JP, Eriksson U, Lampson LA. J. Immunol. 137, 2561-2566, 1986. PDF
Distribution of beta 2-microglobulin in olfactory epithelium: a proliferating neuroepithelium not protected by a blood-tissue barrier.
Whelan JP, Wysocki CJ, Lampson LA. J. Immunol. 137, 2567-2571, 1986. PDF
Immunoblot specificity of monoclonal antibodies assayed against complex extracts.
Lampson LA, Fisher CA. Anal. Biochem. 144, 55-64, 1985. PubMed
HLA-A,B,C and beta 2-microglobulin are expressed weakly by human cells of neuronal origin, but can be induced in neuroblastoma cell lines by interferon. Lampson LA, Whelan JP, Fisher CA. Prog Clin Biol Res 175, 379-388, 1985. PubMed
Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes.
Main EK, Lampson LA, Hart MK, Kornbluth J, Wilson DB. J. Immunol. 135, 242-246, 1985. PDF
HLA class I and beta 2-microglobulin expression in frozen and formaldehyde-fixed paraffin sections of neuroblastoma tumors.
Whelan JP, Chatten J, Lampson LA. Cancer Res. 45, 5976-5983, 1985. PDF
Molecular bases of neuronal individuality: Lessons from anatomical and biochemical studies with monoclonal antibodies.
Lampson L. In Monoclonal Antibodies and Functional Cell Lines: Progress and Applications (Kennett, R, Bechtol, K, McKearn, T, Eds.), pp 153-189, Plenum Press, New York, 1984. Publisher
Monoclonal antibodies against the voltage-sensitive Na+ channel from mammalian skeletal muscle.
Casadei JM, Gordon RD, Lampson LA, Schotland DL, Barchi RL. Proc. Natl. Acad. Sci. USA 81, 6227-6231, 1984. PDF
Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon.
Lampson LA, Fisher CA. Proc. Natl. Acad. Sci. USA 81, 6476-6480, 1984. PDF
Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.
Lampson LA, Fisher CA, Whelan JP. J. Immunol. 130, 2471-2478, 1983. PDF
Paucity of HLA-A,B,C molecules on human cells of neuronal origin: microscopic analysis of neuroblastoma cell lines and tumor.
Lampson LA, Whelan JP. Ann. N. Y. Acad. Sci. 420, 107-114, 1983. PubMed
Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA, Lampson LA, Strominger JL. J. Immunol. 130, 289-296, 1983. PDF
Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.
Shaw S, DeMars R, Schlossman SF, Smith PL, Lampson LA, Nadler LM. J. Exp. Med. 156, 731-743, 1982. PDF
Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA, Lampson LA, Strominger JL. J. Immunol. 127, 1403-1410, 1981. PDF
Two populations of Ia-like molecules on a human B cell line.
Lampson LA, Levy R. J. Immunol. 125, 293-299, 1980. PDF
A role for clonal antigens in cancer diagnosis and therapy.
Lampson LA, Levy R. J. Natl. Cancer Inst. 62, 217-220, 1979. PubMed
Human normal and leukemia cell surface antigens. Mouse monoclonal antibodies as probes.
Levy R, Dilley J, Lampson LA. Curr. Top. Microbiol. Immunol. 81, 164-169, 1978. PubMed
Production in vitro of murine antibody to a human histocompatibility alloantigen.
Lampson LA, Levy R, Grumet FC, Ness D, Pious D. Nature 271, 461-462, 1978. PubMed
Homogeneous antibodies directed against human cell surface antigens: I. The mouse spleen fragment culture response to T and B cell lines derived from the same individual. Lampson LA, Royston I, Levy R. J Supramol Struct 6, 441-448, 1977. PubMed
Meeting Abstracts
Tumor Growth - and immunotherapy - in different brain compartments: revisiting the choroid plexus. MO-19.
Lampson LA, Tripp, CA. In Thirteenth Annual Meeting of the Society for Neuro-Oncology, pp 759-915, Neuro-Oncology, Las Vegas, 2008. Abstract
Lampson LA, Tripp, CA. In Thirteenth Annual Meeting of the Society for Neuro-Oncology, pp 759-915, Neuro-Oncology, Las Vegas, 2008. Abstract
Tailoring immunotherapy to brain metastases.
Lampson LA, Tripp CA. In MRS-AACR Joint Conference on Metastasis, Vancouver, 2008.
Lampson LA, Tripp CA. In MRS-AACR Joint Conference on Metastasis, Vancouver, 2008.
Where do blood-borne cells enter the brain?
Lampson LA, Tripp CA. In Immunology 2007, p S195, J Immunol, Miami Beach, 2007. Abstract
Lampson LA, Tripp CA. In Immunology 2007, p S195, J Immunol, Miami Beach, 2007. Abstract
Antibody-secreting cells to deliver antibody against brain metastases.
Lampson LA, Tripp CA. In J Clin Oncol (Meeting Abstracts) 25, 3047, Chicago, 2007. Abstract
Lampson LA, Tripp CA. In J Clin Oncol (Meeting Abstracts) 25, 3047, Chicago, 2007. Abstract
Rat tumor at different brain sites and its clinical relevance: Blood-borne micro-metastases in the brain proper vs expanding tumor in the ventricle. Tripp CA, Kondo Y, Lampson LA. In 59th Annual Meeting of the American Academy of Neurology, Boston, 2007.
A rat model to study early micro-metastases in the brain: LB308.
Tripp CA, Lampson LA. In American Association of Neuropathologists (AANP) J Neuropathol Exp Neurol 66, 457-458, 2007.
Tripp CA, Lampson LA. In American Association of Neuropathologists (AANP) J Neuropathol Exp Neurol 66, 457-458, 2007.
Tumor in the ventricle: A rat model and its uses.
Lampson LA, Tripp CA. In Eleventh Annual Meeting of the Society for Neuro-Oncology pp 391-500, Neuro Oncology Orlando, 2006. Abstract
Lampson LA, Tripp CA. In Eleventh Annual Meeting of the Society for Neuro-Oncology pp 391-500, Neuro Oncology Orlando, 2006. Abstract
Reproducible blood-borne micro-metastases in the brain proper: A syngeneic rat model.
Tripp CA, Hurley ML, Lampson LA. In Eleventh Annual Meeting of the Society for Neuro-Oncology pp 391-500, Neuro Oncology, Orlando, 2006. Abstract
Tripp CA, Hurley ML, Lampson LA. In Eleventh Annual Meeting of the Society for Neuro-Oncology pp 391-500, Neuro Oncology, Orlando, 2006. Abstract
Visualizable tumor in the choroid plexus of immunocompetent rats: A tool to test therapies for choroid plexus carcinoma (CPC), a grim tumor of childhood, and other brain tumors at that site. Lampson LA, Tripp CA. In 97th Annual Meeting of the American Association for Cancer Research, p 648a, AACR, Washington DC, 2006. Abstract
Blood-borne metastases with different patterns of entry to the brain.
Lampson LA, Tripp CA, Hurley ML. In Immunology 2006, AAI, Boston, 2006.
Lampson LA, Tripp CA, Hurley ML. In Immunology 2006, AAI, Boston, 2006.